Establishment of a mammary carcinoma cell line from Syrian hamsters treated with N-methyl-N-nitrosourea

Cancer Letters

Volumn 312, Issue 1, 2011, Pages 82-90

  Coburn, Malari A ^a   Brueggemann, Sabrina ^c   Bhatia, Shilpa ^a   Cheng, Bing ^a   Li, Benjamin D L ^a,b   Li, Xiao Lin ^a   Luraguiz, Natalia ^a   Maxuitenko, Yulia Y ^d   Orchard, Elysse A ^a   Zhang, Songlin ^a   Stoff Khalili, Mariam A ^c   Mathis, J Michael ^a   Kleiner Hancock, Heather E ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University Health Sciences Center at Shreveport   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

^d SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

Adenocarcinoma; Breast cancer; HMAM5 cell line; Mammary tumor; MNU; N methyl N nitrosourea; Syrian hamster

Indexed keywords

AGAR; CYTOKERATIN; CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; METHYLNITROSOUREA; PANCYTOKERATIN; PROTEIN P63; TAMOXIFEN; UNCLASSIFIED DRUG;

ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GRADING; CANCER INCIDENCE; CANCER TRANSPLANTATION; CELL PROLIFERATION; CELL STRUCTURE; CHROMOSOME NUMBER; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GROWTH RATE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; PRECANCER; PRIORITY JOURNAL; SYRIAN HAMSTER; TUMOR DIFFERENTIATION; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; CARCINOGENS; CELL LINE, TUMOR; CRICETINAE; DISEASE MODELS, ANIMAL; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MESOCRICETUS; METHYLNITROSOUREA;

CRICETINAE; MESOCRICETUS AURATUS;

EID: 80053326150     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.08.003     Document Type: Article

References (31)

1. Ottewell P.D., Coleman R.E., Holen I. From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies. Breast Cancer Res. Treat. 2006, 96(2):101-113.
2. Cianfrocca M., Gradishar W. New molecular classifications of breast cancer. CA Cancer J. Clin. 2009, 59(5):303-313.
3. Gimenez-Conti I.B., Slaga T.J. The hamster cheek pouch carcinogenesis model. J. Cell Biochem. Suppl. 1993, 17F:83-90.
4. Devanesan P., Todorovic R., Zhao J., Gross M.L., Rogan E.G., Cavalieri E.L. Catechol estrogen conjugates and DNA adducts in the kidney of male Syrian golden hamsters treated with 4-hydroxyestradiol: potential biomarkers for estrogen-initiated cancer. Carcinogenesis 2001, 22(3):489-497.
5. Laurent G., Nonclercq D., Journe F., Brohee R., Toubeau G., Falmagne P., Heuson-Stiennon J.A. Characterization of a cell line established from diethylstilbestrol-induced renal tumors in Syrian hamsters. In Vitro Cell Dev. Biol. Anim. 1999, 35(6):339-345.
6. Kaneko T., Tahara S., Takabayashi F., Harada N. Inhibitory effect of esculin on oxidative DNA damage and carcinogenesis induced by N-nitrosobis(2-oxopropyl)amine in hamster pancreas. Biofactors 2004, 22(1-4):83-85.
7. Miyauchi M., Nishikawa A., Furukawa F., Nakamura H., Son H.Y., Murakami A., Koshimizu K., Ohigashi H., Hirose M. Inhibitory effects of 1'-acetoxychavicol acetate on N-Nitrosobis(2-oxopropyl)-amine-induced initiation of cholangiocarcinogenesis in Syrian hamsters. Jpn. J. Cancer Res. 2000, 91(5):477-481.
8. Mizumoto K., Tsutsumi M., Denda A., Konishi Y. Rapid production of pancreatic carcinoma by initiation with N-nitroso-bis(2-oxopropyl)amine and repeated augmentation pressure in hamsters. J. Natl. Cancer Inst. 1988, 80(19):1564-1567.
9. Lichtenstein D.L., Spencer J.F., Doronin K., Patra D., Meyer J.M., Shashkova E.V., Kuppuswamy M., Dhar D., Thomas M.A., Tollefson A.E., Zumstein L.A., Wold W.S., Toth K. An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector. Cancer Gene Ther. 2009, 16(8):644-654.
10. Ying B., Toth K., Spencer J.F., Meyer J., Tollefson A.E., Patra D., Dhar D., Shashkova E.V., Kuppuswamy M., Doronin K., Thomas M.A., Zumstein L.A., Wold W.S., Lichtenstein D.L. INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies. Cancer Gene Ther. 2009, 16(8):625-637.
11. Thomas M.A., Spencer J.F., La Regina M.C., Dhar D., Tollefson A.E., Toth K., Wold W.S. Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors. Cancer Res. 2006, 66(3):1270-1276.
12. Porta G.D. Induction of intestinal, mammary, and ovarian tumors in hamsters with oral administration of 20-methylcholanthrene. Cancer Res. 1961, 21:575-579.
13. Rustia M., Shubik P. Effects of transplacental exposure to diethylstilbestrol on carcinogenic susceptibility during postnatal life in hamster progeny. Cancer Res. 1979, 39(11):4636-4644.
14. Steele V.E., Moon R.C., Lubet R.A., Grubbs C.J., Reddy B.S., Wargovich M., McCormick D.L., Pereira M.A., Crowell J.A., Bagheri D., et al. Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program. J. Cell Biochem. Suppl. 1994, 20:32-54.
15. Dolezalova V., Rejthar A., Sugar J., Toth J., Vermousek I. Phenotypic variability of chemically induced primary rat mammary tumors. Neoplasma 1989, 36(1):103-112.
16. Kleiner H.E., Krishnan P., Tubbs J., Smith M., Meschonat C., Shi R., Lowery-Nordberg M., Adegboyega P., Unger M., Cardelli J., Chu Q., Mathis J.M., Clifford J., De Benedetti A., Li B.D. Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer. J. Exp. Clin. Cancer Res. 2009, 28:5.
17. Seabright M. A rapid banding technique for human chromosomes. Lancet 1971, 2(7731):971-972.
18. Liu C., Zhang H., Shuang C., Lu Y., Jin F., Xu H., Lu P. Alternations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications. Med. Oncol. 2009.
19. Ribeiro-Silva A., Ramalho L.N., Garcia S.B., Brandao D.F., Chahud F., Zucoloto S. p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer. Histopathology 2005, 47(5):458-466.
20. Matos I., Dufloth R., Alvarenga M., Zeferino L.C., Schmitt F. p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch. 2005, 447(4):688-694.
21. Sharma S., Salehi F., Scheithauer B.W., Rotondo F., Syro L.V., Kovacs K. Role of MGMT in tumor development, progression, diagnosis, treatment and prognosis. Anticancer Res. 2009, 29(10):3759-3768.
22. Ariazi J.L., Haag J.D., Gould M.N. Methylguanine methyltransferase activity deficiency in immature rat mammary epithelial cells parallels increased carcinogenic susceptibility. Mol. Carcinog. 2005, 44(3):193-201.
23. Ariazi J.L., Haag J.D., Lindstrom M.J., Gould M.N. Mammary glands of sexually immature rats are more susceptible than those of mature rats to the carcinogenic, lethal, and mutagenic effects of N-nitroso-N-methylurea. Mol. Carcinog. 2005, 43(3):155-164.
24. Mirzaee S., Eriksson S., Albertioni F. Differences in cytosolic and mitochondrial 5'-nucleotidase and deoxynucleoside kinase activities in Sprague-Dawley rat and CD-1 mouse tissues: implication for the toxicity of nucleoside analogs in animal models. Toxicology 2010, 267(1-3):159-164.
25. Quintieri L., Fantin M., Palatini P., De Martin S., Rosato A., Caruso M., Geroni C., Floreani M. In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: a comparison with human liver microsomes. Biochem. Pharmacol. 2008, 76(6):784-795.
26. Spencer J.F., Sagartz J.E., Wold W.S., Toth K. New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster. Cancer Gene Ther. 2009, 16(12):912-922.
27. Thomas M.A., Spencer J.F., Wold W.S. Use of the Syrian hamster as an animal model for oncolytic adenovirus vectors. Methods Mol. Med. 2007, 130:169-183.
28. Duncan S.J., Gordon F.C., Gregory D.W., McPhie J.L., Postlethwaite R., White R., Willcox H.N. Infection of mouse liver by human adenovirus type 5. J. Gen. Virol. 1978, 40(1):45-61.
29. Ginsberg H.S., Moldawer L.L., Sehgal P.B., Redington M., Kilian P.L., Chanock R.M., Prince G.A. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 1991, 88(5):1651-1655.
30. Eggerding F.A., Pierce W.C. Molecular biology of adenovirus type 2 semipermissive infections. I. Viral growth and expression of viral replicative functions during restricted adenovirus infection. Virology 1986, 148(1):97-113.
31. Silverstein G., Strohl W.A. Restricted replication of adenovirus type 2 in mouse Balb/3T3 cells. Arch. Virol. 1986, 87(3-4):241-264.